Sector footprint
$73.5K in exports
Reported chemicals exports in 2024 across 21 qualifying HS6 products.
Sector export playbook ยท HS 28-38
Explore Kiribati's HS 28-38 product portfolio, buyer markets, growth signals, and diversification opportunities. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Chemicals capability
Compare exporter scale with product breadth, buyer demand, growth, and destination reach. A large sector does not remove the need for product, compliance, pricing, and buyer validation.
Sector footprint
Reported chemicals exports in 2024 across 21 qualifying HS6 products.
Global demand
The sector's reported buyer import base provides context for product and market prioritization.
How to use the guide
Start with products that combine demand and exporter capability, then validate standards, route economics, buyers, and competition.
Product portfolio
Each HS6 product is ranked by calculated opportunity and shown with reported market size, exporter exports, growth, and destination reach.
| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
|---|---|---|---|---|---|---|
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $76.8B | $101.5 | $19.0B | -38.0% | 2 | +0.0% |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $1.1B | $484.8 | $794.5M | +10.3% | 2 | +0.0% |
| HS 300590Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | $928.2M | $5.4K | $410.8M | -27.0% | 2 | +0.2% |
| HS 370790Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $478.9M | $1.7K | $380.9M | -37.5% | 1 | +0.0% |
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $1.1B | $1.1K | $336.6M | +13.9% | 1 | +0.0% |
| HS 300220Vaccines: for human medicine | $401.0M | $129.1 | $281.6M | +4.4% | 2 | +0.0% |
| HS 380991Finishing agents and dye carriers: to accelerate dyeing or fixing of dye-stuffs, other products and preparations, used in the textile industry (excluding those with a basis of amylaceous substances) | $240.2M | $5.4K | $174.8M | -9.7% | 1 | +0.0% |
| HS 300610Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents, absorbable surgical or dental haemostatics, and surgical or dental adhesion barriers | $101.3M | $449.7 | $75.0M | -26.2% | 1 | +0.0% |
| HS 330690Oral or dental hygiene preparations: other than dentifrices | $20.3M | $669.0 | $12.9M | -24.0% | 1 | +0.0% |
| HS 340211Organic surface-active agents: anionic (other than soap), whether or not put up for retail sale | $18.5M | $41.2K | $10.8M | +22.7% | 1 | +0.2% |
| HS 370110Photographic plates and film: for x-ray, in the flat, sensitised, unexposed, of any material other than paper, paperboard or textiles | $19.4M | $4.8K | $7.1M | -41.9% | 1 | +0.0% |
| HS 300670Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $11.1M | $46.1 | $4.6M | +6.3% | 1 | +0.0% |
| HS 300390Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.0M | $518.9 | $2.0M | -6.0% | 1 | +0.0% |
| HS 350699Glues and other adhesives: prepared, n.e.s. in heading no. 3506, not exceeding a net weight of 1kg | $3.4M | $23.3 | $1.8M | -15.8% | 2 | +0.0% |
| HS 321410Mastics: painters' fillings | $2.1M | $106.0 | $1.3M | -14.9% | 1 | +0.0% |
| HS 300230Vaccines: for veterinary medicine | $863.0K | $4.5K | $1.2M | +84.1% | 1 | +7.9% |
| HS 300439Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $1.6M | $35.9 | $1.1M | -28.2% | 1 | +0.0% |
| HS 300450Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | $1.1M | $609.1 | $917.9K | -31.5% | 1 | +0.3% |
| HS 300410Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | $1.2M | $1.4K | $667.9K | -27.8% | 1 | +0.2% |
| HS 320890Paints and varnishes: based on polymers n.e.s. in heading no. 3208, dispersed or dissolved in a non-aqueous medium | $1.2M | $4.7K | $518.8K | +9.1% | 1 | +0.6% |
| HS 300449Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $589.7K | $11.5 | $486.5K | -34.2% | 1 | +0.1% |
Best markets
Markets are ranked by calculated opportunity across the qualifying products in this sector view.
USA
4 products represented in the sector.
$19.8B$78.3B reported buyer importsCAN
1 products represented in the sector.
$790.7M$1.1B reported buyer importsARE
1 products represented in the sector.
$336.6M$1.1B reported buyer importsKOR
1 products represented in the sector.
$278.7M$395.8M reported buyer importsDEU
1 products represented in the sector.
$174.8M$240.2M reported buyer importsAUS
2 products represented in the sector.
$79.6M$112.4M reported buyer importsFJI
13 products represented in the sector.
$25.6M$48.6M reported buyer importsIRL
1 products represented in the sector.
$12.9M$20.3M reported buyer importsPAK
1 products represented in the sector.
$10.8M$18.5M reported buyer importsVUT
1 products represented in the sector.
$460.7K$393.4K reported buyer importsGrowth stars
Average product-level CAGR is a screening signal. Confirm the latest trend, base effects, buyer quality, and commercial feasibility before acting.
| Product | Average CAGR | Opportunity | Markets |
|---|---|---|---|
| HS 300230Vaccines: for veterinary medicine | +84.1% | $1.2M | 1 |
| HS 340211Organic surface-active agents: anionic (other than soap), whether or not put up for retail sale | +22.7% | $10.8M | 1 |
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | +13.9% | $336.6M | 1 |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | +10.3% | $794.5M | 2 |
| HS 320890Paints and varnishes: based on polymers n.e.s. in heading no. 3208, dispersed or dissolved in a non-aqueous medium | +9.1% | $518.8K | 1 |
| HS 300670Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | +6.3% | $4.6M | 1 |
| HS 300220Vaccines: for human medicine | +4.4% | $281.6M | 2 |
| HS 300390Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | -6.0% | $2.0M | 1 |
| HS 380991Finishing agents and dye carriers: to accelerate dyeing or fixing of dye-stuffs, other products and preparations, used in the textile industry (excluding those with a basis of amylaceous substances) | -9.7% | $174.8M | 1 |
| HS 321410Mastics: painters' fillings | -14.9% | $1.3M | 1 |
Diversification opportunities
Destination count is a simple breadth indicator. It does not measure destination concentration or guarantee resilience.
HS 300490
HS 382200
HS 300590
HS 300220
HS 350699
HS 370790
HS 330499
HS 380991
Frequently asked questions
Practical guidance for interpreting sector scale, growth, product breadth, and buyer markets.
Compare sector exports, product breadth, buyer markets, growth, and global demand. These signals identify research priorities rather than guarantee market access.
Products with higher average reported growth in the screened rows. Validate the time period, base effects, buyer demand, and current exporter position.
Products reaching more buyer markets in the screened data. Destination breadth is useful context but does not replace concentration, route, or buyer analysis.
Data source
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.